Returning guest, Dr. Michael Korn, Chief Medical Officer at Caris® Life Sciences discusses new data presented at the European Society for Medical Oncology (ESMO) Virtual Congress 2020 from a study that supports that the treatment of certain ovarian cancer patients with KRAS-mutated epithelial ovarian carcinomas (EOC) may benefit from targeted therapies designed to inhibit KRAS gene response. He also talks about additional presentations that reveal the potential impact of precision medicine using Caris’ industry-leading technology.
Dr. Daniel Monti, MD, Founding Director and CEO of the Marcus Institute of Integrative Health shares some simple tips for staying healthy while working from home and avoid conditions such as shattered teeth from slumping on the couch or anxiety due to over caffeinating. He is also the author of the book “Tapestry of Health: Weaving Wellness into Your Life Through the New Science of Integrative Medicine”
Author, Jill Rosensweig, discusses her new children’s book “Bailey Bloom and the Battle of the Bug”, (July 2020) which just received the 2020 Gold Mom’s Choice Award. Parents can use this book as a resource to facilitate discussions with their children about Covid-19, both in terms of what it is and how it is affecting them. A portion of the proceeds from every sale will go to Save the Children, a non-profit organization, which is supporting schools and community programs to feed hungry bellies and minds during the pandemic. Save the Children is also delivering medical supplies and hosting training around the globe to help health care workers protect themselves.
Spiro Rombotis, President and CEO of Cyclacel Pharmaceuticals, a developer of novel therapies that target various phases of cell cycle control for the treatment of cancer and other serious diseases, discusses 3 programs currently in the pipeline for the treatment of various cancers; a transcriptional regulation program, a mitosis regulation program, and a DNA damage response program.
Brad Chapman, Head of Internal Operations and West Ecosystems for U.S. Neurology at UCB, Inc., and Professor Swapna Reddy, Clinical Assistant Professor at Arizona State University’sSchool for the Science of Health Care Delivery, College of HealthSolutions discuss a recent research project looking into how social determinants of Health (SDH) affect the epilepsy community. The project is dedicated to analyzing and evaluating the potential correlation between SDH and epilepsy treatment gaps and health outcomes at a community level and how patients can be better supported in managing their disease. To date, there has been a remarkable absence in research and information on how factors other than the quality of healthcare received can influence outcomes for epilepsy patients.
Dr. Seth Lederman, M.D., co-founder, CEO, and chairman of Tonix Pharmaceuticals Holding Corp., discusses their COVID-19 vaccine program based on their proprietary synthetic horsepox vaccine platform, and how they are currently collaborating with Southern Research, Columbia University, and others. Their vaccine is on course to Phase 1 in early 2021.
Josh Claman, MBA, CEO of Rimidi, a healthcare technology company, discusses how and why technology such as remote patient monitoring and telehealth should be used to predict future outbreaks and serve as early warning systems for detecting viruses in individuals. He also talks about how to address minority health inequities exposed during COVID-19.
James Archetto, Vice President at Gaumard Scientific, designers and manufacturers of state-of-the-art, robot-like, patient simulators, discusses the advantages of simulation-based training and how it is improving COVID-19 readiness along with helping clinicians to develop the skills to use a ventilator. The simulators are incredibly life-like and engage the emotions of the learner.
Dr. Maria Milla, M.D., Section Chief, Nicklaus Children’s Pediatric Care Centers discusses pediatric immunizations and the recommendation to not delay whether children are attending classes in person or virtually. Delaying vaccinations, especially during a pandemic, can put many children at risk with unnecessary hospitalizations and office visits.
Dr. Tim Rodell, M.D., CEO and Director at Aethlon Medical, Inc., discusses the Hemopurifier®, a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The Hemopurifier has existing Investigational Device Exemption in cancer and life-threatening viral infections and the FDA has recently supplemented to its IDE in viral disease to include SARS-CoV-2/COVID-19. In 2014, a Ugandan pediatrician who had been treating Ebola patients became infected himself. The Hemopurifier was used to extract the virus from the pediatrician’s blood and ultimately saved his life.